Tumor Response Time of Palbociclib in Combination With AI in Real-world Chinese Patients
Clinical trial NCT04858997 · UNKNOWN
Trial details
- NCT number
- NCT04858997
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2022-12-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.